CINECA IRIS Institutional Research Information System

PEROTTI, Paola Carla Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.310
EU - Europa 1.649
AS - Asia 919
SA - Sud America 179
OC - Oceania 45
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.231
IT - Italia 400
CN - Cina 319
DE - Germania 183
SE - Svezia 172
JP - Giappone 133
SG - Singapore 126
IE - Irlanda 125
FR - Francia 123
UA - Ucraina 96
ES - Italia 73
GB - Regno Unito 65
PL - Polonia 65
BR - Brasile 64
TR - Turchia 60
VN - Vietnam 60
FI - Finlandia 55
CA - Canada 50
AR - Argentina 46
HU - Ungheria 45
IN - India 42
AT - Austria 37
AU - Australia 37
KR - Corea 36
GR - Grecia 32
BE - Belgio 30
CO - Colombia 30
RU - Federazione Russa 30
HK - Hong Kong 29
ID - Indonesia 28
MX - Messico 21
NL - Olanda 21
CL - Cile 17
IL - Israele 15
TW - Taiwan 14
CH - Svizzera 13
DZ - Algeria 13
DK - Danimarca 12
HR - Croazia 12
PT - Portogallo 12
TH - Thailandia 12
CZ - Repubblica Ceca 11
MY - Malesia 11
PE - Perù 9
ZA - Sudafrica 9
NZ - Nuova Zelanda 8
SI - Slovenia 8
BA - Bosnia-Erzegovina 7
PH - Filippine 7
RO - Romania 7
EC - Ecuador 6
TN - Tunisia 6
DO - Repubblica Dominicana 4
JO - Giordania 4
OM - Oman 4
SY - Repubblica araba siriana 4
UZ - Uzbekistan 4
VE - Venezuela 4
EG - Egitto 3
EU - Europa 3
IR - Iran 3
LV - Lettonia 3
MU - Mauritius 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
UY - Uruguay 3
CU - Cuba 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MA - Marocco 2
NO - Norvegia 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
BG - Bulgaria 1
BY - Bielorussia 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.146
Salva come PNG Salva come JPEG
Città #
Chandler 306
Fairfield 167
Beijing 130
Dublin 121
Singapore 110
Ashburn 109
Houston 97
Woodbridge 86
Seattle 84
Ann Arbor 83
Cambridge 79
Redwood City 79
Torino 79
Wilmington 61
Nyköping 59
Jacksonville 50
Turin 45
Dong Ket 42
Columbus 36
Medford 36
Pisa 36
Munich 34
Princeton 34
Vienna 31
Budapest 29
Jakarta 28
Würzburg 27
Guangzhou 26
New York 26
Dearborn 23
Villeurbanne 23
Warsaw 23
Buenos Aires 22
Fremont 22
Milan 21
Okazaki 21
Boston 20
Shanghai 20
Paris 19
Bogotá 17
Ankara 16
Lappeenranta 16
Athens 14
Los Angeles 14
Tokyo 14
Moscow 12
Rochester 12
San Diego 12
Brescia 11
Fukuoka 11
Istanbul 11
Uberlândia 11
Hong Kong 10
Szekszárd 10
Brussels 9
Chengdu 9
Hangzhou 9
Helsinki 9
Lima 9
Santa Clara 9
Amsterdam 8
Brisbane 8
Brno 8
Curitiba 8
Durham 8
Polska 8
Soliera 8
Taipei 8
Zagreb 8
Berlin 7
Delhi 7
Girona 7
Katowice 7
Madrid 7
Portland 7
Santiago 7
Toronto 7
Washington 7
Bad Zwischenahn 6
Bozeman 6
Canberra 6
Cleveland 6
Düsseldorf 6
Gumyojicho 6
Hamamatsu 6
Hefei 6
Kayseri 6
Logroño 6
Longueuil 6
Matawan 6
Molina de Segura 6
Nanjing 6
Naples 6
Norfolk 6
Osaka 6
Pasto 6
Rome 6
Seoul 6
Silver Spring 6
Bangkok 5
Totale 2.855
Salva come PNG Salva come JPEG
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 1.154
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 314
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. 314
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 312
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 281
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 252
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 234
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 158
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines 154
Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity. 124
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 116
Adrenocortical Carcinoma with Hypercortisolism. 115
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 112
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 109
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 107
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 103
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 102
Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics 95
Mitotane: new facts for an old drug 94
Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression 91
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 78
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome 77
Aluminium blunts the proliferative response and increases apoptosis of cultured human cells: putative relationship to alzheimer's disease 72
PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA. 71
Metronomic therapy concepts in the management of adrenocortical carcinoma. 60
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies 59
Immunotherapy failure in adrenocortical cancer: Where next? 56
A current perspective on treatment of adrenocortical carcinoma 55
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma 51
Phase II study of weekly paclitaxel and sorafenib as second/third line therapy in patients with adrenocortical carcinoma. 48
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question 47
Chemotherapy 43
Gemcitabine-based chemotherapy in adrenocortical carcinoma: A multicenter study of efficacy and predictive factors 42
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study 39
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 34
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 34
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 23
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. 19
Adrenal cortical carcinoma: mitotane and beyond 18
Comparison of “IN-REC-SUR-E” and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial) 16
null 10
Serendipitous Adrenal Hyperplasia in Patients Admitted to the Emergency Department for Suspected SARS-CoV-2 Infection is Linked to Increased Mortality 7
Totale 5.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.683
article - articoli 0
book - libri 0
conference - conferenze 834
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020460 0 0 0 0 30 71 55 80 90 56 33 45
2020/2021689 45 46 64 38 40 38 60 60 36 68 73 121
2021/2022960 62 44 58 94 78 50 55 70 55 117 168 109
2022/20231.167 106 102 43 114 73 207 63 77 142 47 102 91
2023/2024926 82 128 64 74 84 84 56 90 27 74 83 80
2024/2025437 84 107 100 119 27 0 0 0 0 0 0 0
Totale 5.300